Thrombocytopenia, rash, and other adverse events were also commonly reported; however, these findings did not reach statistical significance.
← all excerpts
PD-1 inhibitors improve the efficacy of transcatheter arterial chemoembolization combined with apatinib in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis.
1
—
—